ClinConnect ClinConnect Logo
Search / Trial NCT06921421

Assessment Of Burn Severity and Extent Spatial Frequency Domain Imaging

Launched by THE METIS FOUNDATION · Apr 8, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Sfdi Spatial Frequency Domain Imaging Burn Depth Burn Injury Assessment

ClinConnect Summary

This clinical trial is looking at a new way to assess the severity of burns using a special imaging technique called Spatial Frequency Domain Imaging (SFDI). The aim is to see if this technology, which has shown promise in earlier studies, can help doctors accurately determine how deep a burn is and how large the affected area is within the first 24 hours after an injury. This information is crucial for doctors to decide the best treatment for patients with burns. The study will compare two different SFDI devices, the Clarifi Imaging System and the handheld m-Clarifi, to see if they provide similar results in assessing burn injuries.

To participate in the trial, individuals must be at least 18 years old and have thermal burns of any depth, whether superficial or deeper. Unfortunately, those under 18, as well as pregnant or breastfeeding women, are not eligible to join. While the study is not yet recruiting participants, those who take part can expect to undergo imaging tests to help guide their treatment, contributing to important research that could benefit future burn patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients 18 years of age or older
  • 2. Thermal burns of any depth (superficial, deep partial thickness, or full thickness).
  • Exclusion Criteria:
  • 1. Patients less than 18 years of age
  • 2. Pregnant or breastfeeding women

About The Metis Foundation

The Metis Foundation is a dedicated clinical trial sponsor focused on advancing medical research and innovation to improve patient outcomes. With a commitment to ethical practices and scientific rigor, the Foundation collaborates with healthcare professionals, academic institutions, and industry partners to facilitate the development of novel therapies and interventions. By prioritizing patient safety and data integrity, the Metis Foundation aims to contribute to the growing body of knowledge in various medical fields and support the translation of research findings into effective clinical applications.

Locations

Fort Sam Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Rodney Chan, MD

Principal Investigator

The Metis Foundation

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported